{"id":"W2892397412","doi":"10.1200/jco.2018.36.30_suppl.260","title":"Safety and clinical efficacy of programmed cell death 1 antibodies (PD-1 Ab) in patients with advanced non-small cell lung cancer (NSCLC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Lung cancer; Pembrolizumab; Gastroenterology; Pneumonitis; Hazard ratio; Atezolizumab; Adverse effect; Clinical trial; Cancer; Proportional hazards model; Oncology; Surgery; Lung; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001258373,0.0001754519,0.000406759,0.0002612476,0.0001979672,0.0005478295,0.0002300733,0.0003026953,0.0007804646],"category_scores_gemma":[0.002011364,0.0001378523,0.000572923,0.0002261075,0.0002434052,0.0003426571,0.0002901965,0.0004865454,0.0002184073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006094862,"about_ca_system_score_gemma":0.0004786672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003440923,"about_ca_topic_score_gemma":0.0006212714,"domain_scores_codex":[0.9996063,0.0001360485,0.00003632403,0.0000771319,0.000104082,0.00004021394],"domain_scores_gemma":[0.9987267,0.0003594464,0.000543728,0.000053771,0.00007572577,0.0002406555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05002952,0.001318489,0.8523332,0.0003403949,0.0005829268,0.000354273,0.000142465,0.001088357,0.004808298,0.0001165141,0.001166486,0.08771914],"study_design_scores_gemma":[0.003828432,0.04376436,0.9447061,0.00005535292,0.0003989353,0.0008719754,0.00007731789,0.002028137,0.001189224,0.0002477993,0.00281814,0.00001409576],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967766,0.001730049,0.0001316489,0.00009351051,0.00001510107,0.00005129458,0.0003439822,0.000008295097,0.0008495051],"genre_scores_gemma":[0.9989447,0.0002611681,0.00008294186,0.0000702247,0.00002311791,0.00002586513,0.0004348693,0.000001279856,0.0001558257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001258373,"threshold_uncertainty_score":0.006654978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03985373396651216,"score_gpt":0.4225818550272784,"score_spread":0.3827281210607662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}